beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial.

Autor: Cullen KJ, Schumaker L, Nikitakis N, Goloubeva O, Tan M, Sarlis NJ, Haddad RI, Posner MR
Zdroj: Journal of Clinical Oncology; 12/20/2009, Vol. 27 Issue 36, p6222-6228, 7p
Databáze: Supplemental Index